• OPEN AN ACCOUNT
Indian Indices
Nifty
25,868.60 25.45
(0.10%)
Sensex
84,426.34 62.97
( 0.07%)
Bank Nifty
58,007.20 -26.00
( -0.04%)
Nifty IT
35,299.75 7.15
( 0.02%)
Global Indices
Nasdaq
46,949.45 221.87
(0.47%)
Dow Jones
6,756.75 0.62
(0.01%)
Hang Seng
49,405.00 88.94
(0.18%)
Nikkei 225
9,515.00 88.01
(0.93%)
Forex
USD-INR
87.90 -0.09
(-0.10%)
EUR-INR
102.45 -0.07
(-0.07%)
GBP-INR
117.95 -0.13
(-0.11%)
JPY-INR
0.58 0.00
(-0.13%)

EQUITY - MARKET SCREENER

Welcure Drugs & Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524661
INE331C01025
0.8287585
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
3.36
91.46
EPS(TTM)
Face Value()
Div & Yield %
0.22
1
0
 

netlink solutions (india) ltd
Radhagobind Commercial reports standalone net loss of Rs 0.10 crore in the March 2025 quarter
Jun 01,2025
Net Loss of Radhagobind Commercial reported to Rs 0.10 crore in the quarter ended March 2025 as against net loss of Rs 0.21 crore during the previous quarter ended March 2024. There were no Sales reported in the quarter ended March 2025 and during the previous quarter ended March 2024.

For the full year,net loss reported to Rs 0.39 crore in the year ended March 2025 as against net loss of Rs 7.51 crore during the previous year ended March 2024. There were no Sales reported in the year ended March 2025 and during the previous year ended March 2024.